Is ARAY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARAY. It does not provide personalized investment advice.

ARAY (Accuray Incorporated) Stock Analysis - Financials

Accuray Incorporated (ARAY) is a publicly traded Healthcare sector company. As of September 23, 2026, ARAY trades at $0.24 with a market cap of $28.67M and a P/E ratio of -0.58. ARAY moved +4.35% today. Year to date, ARAY is -72.11%; over the trailing twelve months it is -87.15%. Its 52-week range spans $0.22 to $2.95. Rallies surfaces ARAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ARAY's key financials?

ARAY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ARAY recently traded at $0.24. Market cap is $28.67M. P/E ratio is -0.58. Revenue is $401.95M.

ARAY Key Metrics

Key financial metrics for ARAY
Metric	Value
Price	$0.24
Market Cap	$28.67M
P/E Ratio	-0.58
EPS	$-0.40
Dividend Yield	0.00%
52-Week High	$2.95
52-Week Low	$0.22
Volume	9.29K
Avg Volume	0
Revenue (TTM)	$401.95M
Net Income	$-49.19M
Gross Margin	27.73%

ARAY Analyst Consensus

ARAY analyst coverage data. Average price target: $0.00.

Common questions about ARAY

What are ARAY's key financials?: ARAY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ARAY recently traded at $0.24. Market cap is $28.67M. P/E ratio is -0.58. Revenue is $401.95M.
Is ARAY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARAY. It does not provide personalized investment advice.